Hansen Christopher L, Cen Puxiao, Sanchez Benjamin, Robinson Reginald
Section of Cardiology, Temple University Hospital, Philadelphia, PA 19140, USA.
J Nucl Cardiol. 2002 Jan-Feb;9(1):47-51. doi: 10.1067/mnc.2002.118695.
Elevated lung-heart ratio (LHR) and transient ischemic dilation (TID) have been identified as markers of severe coronary artery disease after both exercise and pharmacologic stress testing. We have previously demonstrated a very weak correlation between elevated LHR and TID after exercise, which suggests that they reflect different pathophysiologic manifestations of coronary disease. Because the physiology of pharmacologic vasodilation with dipyridamole is significantly different than that of physical exercise, we undertook this study to evaluate the relationship between elevated LHR and TID after pharmacologic stress testing with dipyridamole.
We identified 1129 consecutive patients who underwent pharmacologic stress imaging with dipyridamole and thallium 201. LHR and a dilation index were calculated and compared with each other and with relevant clinical parameters. Echocardiographic parameters were also compared in a subset of 475 patients who had echocardiography within 2 weeks of pharmacologic stress testing. There was no significant correlation between elevated LHR and TID despite the fact that both were associated with more severe thallium stress and redistribution scores. Patients with elevated LHR were more likely to have a history of myocardial infarction and coronary artery bypass grafting and to have lower ejection fraction. Patients with TID were more likely to have a positive electrocardiographic response (15% vs 7%, P =.0003), which was not seen in patients with elevated LHR (11% vs 8%, P =.23).
Although both elevated LHR and TID were associated with more severe coronary disease, they have no significant correlation. Patients with elevated LHR are more likely to have a history of myocardial infarction or coronary artery bypass grafting, a larger left ventricle, and lower ejection fraction. Our results support the hypothesis that TID is due to diffuse subendocardial hypoperfusion and represents a different pathophysiologic response to ischemia than elevated LHR.
肺心比(LHR)升高和短暂性缺血性扩张(TID)已被确定为运动和药物负荷试验后严重冠状动脉疾病的标志物。我们之前已经证明运动后LHR升高与TID之间的相关性非常弱,这表明它们反映了冠状动脉疾病不同的病理生理表现。由于双嘧达莫药物性血管扩张的生理机制与体育锻炼有显著差异,我们进行了这项研究,以评估双嘧达莫药物负荷试验后LHR升高与TID之间的关系。
我们纳入了1129例连续接受双嘧达莫和铊201药物负荷显像的患者。计算LHR和扩张指数,并相互比较以及与相关临床参数进行比较。还对475例在药物负荷试验后2周内进行超声心动图检查的患者亚组的超声心动图参数进行了比较。尽管LHR升高和TID均与更严重的铊负荷及再分布评分相关,但两者之间无显著相关性。LHR升高的患者更可能有心肌梗死和冠状动脉搭桥手术史,且射血分数较低。TID患者更可能有心电图阳性反应(15%对7%,P = 0.0003),而LHR升高的患者未出现这种情况(11%对8%,P = 0.23)。
虽然LHR升高和TID均与更严重的冠状动脉疾病相关,但它们之间无显著相关性。LHR升高的患者更可能有心肌梗死或冠状动脉搭桥手术史、左心室较大且射血分数较低。我们的结果支持以下假设,即TID是由于弥漫性心内膜下灌注不足所致,并且代表了与LHR升高不同的对缺血的病理生理反应。